Non-alcoholic fatty liver disease in early pregnancy predicts dysglycemia in mid-pregnancy: prospective study

American Journal of Gastroenterology

Volumn 111, Issue 5, 2016, Pages 665-670

  De Souza, Leanne R ^a,b   Berger, Howard ^a,c   Retnakaran, Ravi ^d   Vlachou, Paraskevi A ^a   Maguire, Jonathon L ^c   Nathens, Avery B ^e   Connelly, Philip W ^a,c   Ray, Joel G ^a,b,c,f  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; ALANINE AMINOTRANSFERASE;

ADOLESCENT; ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; DYSGLYCEMIA; ECHOGRAPHY; FEMALE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; NONALCOHOLIC FATTY LIVER; ONTARIO; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME ULTRASOUND SCANNER; SECOND TRIMESTER PREGNANCY; ADULT; BLOOD; COMPLICATION; DIABETES, GESTATIONAL; DIAGNOSTIC IMAGING; FETUS ECHOGRAPHY; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; PREGNANCY; STATISTICAL MODEL;

ADULT; ALANINE TRANSAMINASE; DIABETES, GESTATIONAL; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; LOGISTIC MODELS; NON-ALCOHOLIC FATTY LIVER DISEASE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PROSPECTIVE STUDIES; ULTRASONOGRAPHY, PRENATAL;

EID: 84961227007     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2016.43     Document Type: Article

References (35)

1. Solomon CG, Willett WC, Carey VJ, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 1997; 278: 1078-83
2. Kim CH, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002; 25: 1862-8
3. Retnakaran R, Qi Y, Sermer M, et al. Glucose intolerance in pregnancy and future risk of pre-diabetes or diabetes. Diabetes Care 2008; 31: 2026-31
4. Thompson D, Capes S, Feig DS, et al. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Can J Diabetes 2008, S168-80
5. Targher G, Bertolini L, Padovani R, et al. Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007; 118: 829-38
6. Wahren J, Ekberg K. Splanchnic regulation of glucose production. Annu Rev Nutr 2007; 27: 329-45
7. Porepa L, Ray JG, Sanchez-Romeu P, Booth GL. Newly diagnosed diabetes mellitus as a risk factor for serious liver disease. CMAJ 2010; 182 (11 ): E526-31
8. Despres JP. Abdominal obesity as important component of insulin-resistance syndrome. Nutrition 1993; 9: 452-9
9. Cali AM, De Oliveira AM, Kim H, et al. Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link? Hepatology 2009; 49 (6 ): 1896-903
10. Kalhan SC, Bugianesi E, McCullough AJ, et al. Estimates of glycerneogenesis in type 2 diabetes mellitus in humans. Metabolism 2008; 57 (3 ): 305-12
11. Tiikkainen M, Tamminen M, Hakkinen AM, et al. Liver-fat accumulation and insulin resistance in obese women with previous gestational diabetes. Obes Res 2002; 10: 859-67
12. Mishra P, Younossi ZM. Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD). Am J Gastroenterol 2007; 102: 2716-7
13. Hamaguchi M, Kojima T, Itoh Y, et al. The severity of ultrasonographic fi ndings in nonalcoholic fatty liver disease refl ects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007; 102: 2708-15
14. Charatcharoenwitthaya P, Lindor KD. Role of radiologic modalities in the management of non-alcoholic steatohepatitis. Clin Liver Dis 2007; 11: 37-54
15. Sadeeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-50
16. Chang Y, Ryu S, Sung E, et al. Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clin Chem 2007; 53: 686-92
17. Martin AM, Berger H, Nisenbaum R, et al. Abdominal visceral adiposity in the first trimester predicts glucose intolerance in later pregnancy. Diabetes Care 2009; 32: 1308-10
18. International Association of Diabetes and Pregnancy Study Groups Consensus Panel. Metzger BE, Gabbe SG, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classifi cation of hyperglycemia in pregnancy. Diabetes Care 2010; 33: 676-82
19. McCullough AJ. The clinical features, diagnosis and natural history of non-alcoholic fatty liver diease. Clin Liver Dis 2004; 8: 521-33
20. Page L, Girling J. A novel cause for abnormal liver function tests in pregnancy and in the puerperium: non-alcoholic fatty liver disease. BJOG 2011; 118: 1532-5
21. Castracane V, Davis G, Martinez B, et al. Nonalcoholic fatty liver disease in pregnant women. Endocr Abstr 2012; 29: P938
22. Sridhar SB, Xu F, Darbinian J, et al. Pregravid liver enzyme levels and risk of gestational diabetes mellitus during a subsequent pregnancy. Diabetes Care 2014; 37: 1878-84
23. Schindhelm RK, Dekker JM, Nijpels G, et al. No independent association of alanine aminotransferase with risk of future type 2 diabetes in the Hoorn study. Diabetes Care 2005; 28: 2812
24. Forbes S, Taylor-Robinson SD, Patel N, et al. Increased prevalence of non-alcoholic fatty liver disease in European women with a history of gestational diabetes. Diabetologia 2011; 54: 641-7
25. Hagstrom H, Hoijer J, Ludvigsson JF, et al. Adverse outcomes of pregnancy in women with non-alcoholic fatty liver diease. Liver Int 2015
26. Wong VW, Hui AY, Tsang SW, et al. Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2006; 24: 1215-22
27. Manchanayake J, Chitturi S, Nolan C, et al. Postprandial hyperinsulinemia is universal in non-diabetic patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2011; 26: 510-6
28. Mach T. Fatty liver - A current look at the old disease. Med Sci Monit 2000; 6 (1 ): 209-16
29. Bartha JL, Marin-Segura P, Gonzalez-Gonzalez NL, et al. Ultrasound evaluation of visceral fat and metabolic risk factors during early pregnancy. Obesity 2007; 15: 2233-9
30. Ray JG, Berger H, Lipscombe LL, et al. Gestational prediabetes: a new term for early prevention. Indian J Med Res 2010; 132: 251-5
31. Brumbaugh DE, Friedman JE. Developmental origins of non-alcoholic fatty liver disease. Pediatr Res 2014; 75 (1 ): 140-7
32. Brumbaugh DE, Tearse P, Cree-Green M, et al. Intrahepatic fat is increased in neonatal off spring of obese women with gestational diabetes. J Pediatr 2013; 162: 930-6e1
33. Modi N, Murgasova D, Ruager-Martin R, et al. The Influence of maternal body mass index on infant adiposity and hepatic lipid content. Pediatr Res 2011; 70: 287-91
34. Hinkle SN, Sharma AJ, Kim SY, et al. Pre-pregnancy obesity trends among low-income women, United States, 1999-2008. Matern Child Health J 2012; 161: 1339-48
35. Agopian VG, Kaldas FM, Hong JC, et al. Liver transplantation for nonalcoholic steatohepatitis: the new edpidemic. Ann Surg. 2012; 256: 624-33